Sign in

Abstract

We have developed a novel chemical handle (PFI-E3H1) and a chemical probe (PFI-7) as ligands for the Gid4 subunit of the human E3 ligase CTLH degradation complex. Through an efficient initial hit-ID campaign, structure-based drug design (SBDD) and leveraging the sizeable Pfizer compound library, we identified a 500 nM ligand for this E3 ligase through file screening alone. Further exploration identified a vector that is tolerant to addition of a linker for future chimeric molecule design. The chemotype was subsequently optimized to sub-100 nM Gid4 binding affinity for a chemical probe. These novel tools, alongside the suitable negative control also identified, should enable the interrogation of this complex human E3 ligase macromolecular assembly.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers
Citations
18
FWCI
2.00
Field percentile
top 13%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISKotlarek '26Owens '24Chrustowicz '21Zhou '25Sherpa '21Hanzl '23
72% semantic matchMolecular Biology
Daria Kotlarek, Katarzyna Dudek, Bartosz Woźniak+27 more·ChemMedChem·Apr 3, 2026